BeOne Medicines Ltd. (ONC)

BeOne Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,359	19,667	18,862	22,843	27,843	23,494
Market Cap Growth	90.36%	4.27%	-17.43%	-17.96%	18.51%	131.83%
Enterprise Value	33,628	18,005	16,441	19,597	24,626	19,028
Last Close Price	321.36	184.71	180.36	219.94	270.93	258.39
PS Ratio	7.53	5.16	7.67	16.13	23.67	76.06
PB Ratio	9.36	5.90	5.33	5.21	4.54	6.07
P/TBV Ratio	9.54	5.99	5.42	5.26	4.58	6.08
P/OCF Ratio	61.90	-	-	-	-	-
EV/Sales Ratio	7.37	4.72	6.69	13.84	20.94	61.60
Debt / Equity Ratio	0.27	0.32	0.26	0.14	0.11	0.14
Asset Turnover	0.76	0.65	0.40	0.19	0.17	0.09
Inventory Turnover	1.59	1.30	1.09	1.09	0.99	23.18
Quick Ratio	1.65	1.51	1.97	3.22	4.45	4.40
Current Ratio	1.95	1.80	2.32	3.55	4.76	4.61
Return on Equity (ROE)	-4.98%	-18.77%	-22.26%	-38.11%	-29.15%	-67.19%
Return on Assets (ROA)	-1.06%	-6.07%	-12.40%	-15.00%	-12.72%	-28.73%
Return on Capital (ROIC)	-1.37%	-8.01%	-15.99%	-18.95%	-15.97%	-36.44%
Earnings Yield	-0.50%	-3.28%	-4.67%	-8.77%	-5.24%	-6.92%
FCF Yield	0.69%	-3.22%	-9.12%	-7.98%	-5.61%	-5.96%
Buyback Yield / Dilution	-2.33%	-0.86%	-1.22%	-11.15%	-11.16%	-38.99%

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q